Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points

$ 20.99

4.7 (72) In stock

225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy

Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Cancers, Free Full-Text

Low cost, high temporal resolution optical fiber-based γ-photon

Investigation of image-based lesion and kidney dosimetry protocols

Figure 5 from Lu-177-PSMA-617 Prostate-Specific Membrane Antigen

Optimizing treatment activities for [ 225 Ac]Ac-and [ 177 Lu]Lu

SNMMI 2023: Tumour-to-Kidney Ratio on Pre-Therapeutic PSMA-PET-CT

Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T

Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Patient-specific dosimetry adapted to variable number of SPECT/CT

How We Do It: A Multidisciplinary Approach to 177Lu DOTATATE